Fluorodeoxyglucose F18: all 39 studies that test it
Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Imaging Mitochondrial Complex-I in Alcohol Use DisorderRecruitingNCT07825818Early Phase 1
- Glucose Consumption in MS Using [F-18]FDG-PETRecruitingNCT07087106Phase 4
- Ultralow Dose PET Imaging of 18F-FDG UptakeRecruitingNCT06956391Phase 2
- Clinical Study of 18F-Alfatide Injection PET/CTNot yet recruitingNCT06416852Phase 3
- PET Imaging Study of 68Ga-NB381 in Multiple MyelomaRecruitingNCT06385652Early Phase 1
- Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine NeoplasmsEnrolling by invitationNCT05709171Phase 2
- Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer PatientsEnrolling by invitationNCT05396118Phase 2
- Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CTRecruitingNCT05121779Phase 1
- Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial ImagingRecruitingNCT04275453Phase 1/2
- Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted TherapyActive, not recruitingNCT04692103Phase 2Results posted
- F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted TherapyTerminatedNCT02149173Not applicableResults posted
- Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.CompletedNCT01890343Phase 2Results posted
- A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLCCompletedNCT00963807Phase 2Results posted
- FDG-PET/CT in the Evaluation of Patients With Suspected CholecystitisCompletedNCT00590395Not applicableResults posted
- Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRICompletedNCT00537056Not applicableResults posted
- Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal MetastasesCompletedNCT00375830Phase 2Results posted
- Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer PatientsCompletedNCT07553741Not applicable
- Comparison of Whole Body DWI to FDG PETActive, not recruitingNCT06630845Not applicable
- 18F-FAPI PET Imaging in Pancreatic AdenocarcinomaCompletedNCT05884463Not applicable
- A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple MyelomaStatus unknownNCT05448404Not applicable
- 68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma PatientsCompletedNCT05432947Not applicable
- Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT ImagingActive, not recruitingNCT04943211Phase 3
- FDG PET-MRI for the Diagnosis of Spinal Cord LesionsCompletedNCT04219969Not applicable
- Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation TherapyCompletedNCT03493789Phase 1
- Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerTerminatedNCT03432741Phase 1
- Use of PET/MR Imaging in Chronic PainCompletedNCT03195270Phase 1
- Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82CompletedNCT03048097Early Phase 1
- 18F-FLT PET Imaging in Patients With Advanced MelanomaTerminatedNCT02891616Phase 1
- Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot StudyCompletedNCT02678884Not applicable
- NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT02429804Phase 1
- 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or TransplantActive, not recruitingNCT02379377Phase 1
- 18F-FDG PET/CT for IgG4-Related DiseaseStatus unknownNCT01665196Early Phase 1
- Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian CancerTerminatedNCT01494012Phase 1
- Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and WaterTerminatedNCT01246869Phase 1
- Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid TumorsCompletedNCT00816335Early Phase 1
- Evaluation of MorphoTEP With the FDG Among Patients in Severe Sepsis of Unspecified EtiologyStatus unknownNCT00791310Phase 3
- FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer PatientsTerminatedNCT00707213Phase 1
- Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal CancerCompletedNCT00576563Not applicable
- Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional ModalitiesCompletedNCT00001568Phase 2